Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LSD Base and Tartrate Bioequivalence
NCT04865653Phase 1Completed
- Sponsor
- University Hospital Basel
- Start
- Mar 2022
- Primary completion
- Oct 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Lysergide (5 arms), sponsored by University Hospital Basel. Primary endpoints: LSD plasma Area Under the Curve at 18 months, LSD Maximum Plasma Concentration at 18 months and 2 more. Started Mar 2022; status: completed.
02
Drugs
Lysergide
Beyond the preview
Go deeper on NCT04865653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04865653.